Module 2.7 REMS Program Launch Readiness

Select a Module Module Details Review Materials Take Quiz Evaluate Module

Module 2.7 on REMS Program Launch Readiness focuses on the essential operational, procedural, and systemic preparedness required to execute FDA-mandated Risk Evaluation and Mitigation Strategies (REMS) on day one of a product's approval. Emphasizing that the FDA grants no implementation grace period , the module outlines how a failure to achieve day-one readiness can block commercial distribution, delay patient access, and trigger severe regulatory penalties. It maps out the critical responsibilities of cross-functional stakeholders, ranging from regulatory and safety teams to IT and commercial operations, and details the exact readiness standards required for SOPs, validated technology systems, vendor attestations, and budgets. Ultimately, the training provides REMS professionals with a structured risk identification framework and a strict pre-launch timeline (from 90 days out down to the go/no-go milestones) to ensure all elements are fully operational and inspection-ready prior to the PDUFA date.